Samples of the vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology. Reuters
Samples of the vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology. Reuters
Russia’s sovereign wealth fund partners with Pharco to supply Covid-19 vaccine to Egypt
Under the deal, 25 million doses of Sputnik V vaccine will be supplied, enough to cover 25% of its population
